Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.

CONCLUSIONS: IMPT guarantees optimal target coverage, OARs sparing, and simultaneously minimizes the risk of skin morbidity. The applied model-based approach supports the potential clinical relevance of IMPT for left-side BC and RNI and might be relevant for the setup of cost-effectiveness evaluation strategies based on NTCP predictions, as well as for establishing patient selection criteria.
PMID: 30938217 [PubMed - as supplied by publisher]

Source: Acta Oncologica - April 1, 2019 Category: Cancer & Oncology Authors: Fellin F, Iacco M, D'Avino V, Tommasino F, Farace P, Palma G, Conson M, Giacomelli I, Zucchetti C, Falcinelli L, Amichetti M, Aristei C, Cella L Tags: Acta Oncol Source Type: research